Neuropad is a point-of-care test for people with diabetes to diagnose sudomotor dysfunction (inadequate sweat production), in the early stages of diabetic foot neuropathy.
 
Status In progress
Process MT
ID number 318

Provisional Schedule

Draft guidance 22 November 2017 - 20 December 2017
Committee meeting: 3 16 February 2018
Resolution 26 March 2018
Expected publication 10 May 2018

Project Team

Project lead Neil Hewitt

Email enquiries

Stakeholders

External assessment group King's Technology Evaluation Centre (KiTEC)
Manufacturers Skyrocket Phytopharma UK (UK distributor)
  TRIGOcare (manufacturer)
Manufacturers of related technologies not included in scope McCallan Medical Ltd
Others Birmingham Community Healthcare NHS Trust
  Boston Scientific
  Department of Health (DH)
  Healthcare Improvement Scotland (HIS)
  Johnson & Johnson Medical Ltd
  National Institute for Health Research Horizon Scanning Centre (NIHR)
  Medicines and Healthcare Products Regulatory Agency (MHRA)
  NHS England (NHSE)
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Devices for Dignity
  Royal College of Physicians
  Medical Technology Group
  The British In Vitro Diagnostics Association (BIVDA)
Research groups Diabetes Frail

Timeline

Key events during the development of the guidance:

Date Update
20 October 2017 Committee meeting: 2
20 April 2017 Scope published
20 March 2017 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance